Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D019540:Area Under Curve; D005260:Female; D006440:Hemofiltration; D006801:Humans; D053122:Influenza A Virus, H3N2 Subtype; D053124:Influenza A Virus, H5N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D007441:Intubation, Gastrointestinal; D008297:Male; D053139:Oseltamivir / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics*; D011247:Pregnancy; D012121:Respiration, Artificial; D016896:Treatment Outcome; D019562:Viral Load
D000998:Antiviral Agents; D053139:Oseltamivir